Predictors of in-hospital mortality in elderly patients with acute venous thrombo-embolism: the SWIss Venous ThromboEmbolism Registry (SWIVTER)

Eur Heart J. 2012 Apr;33(7):921-6. doi: 10.1093/eurheartj/ehr392. Epub 2011 Oct 27.

Abstract

Aims: Although acute venous thrombo-embolism (VTE) often afflicts patients with advanced age, the predictors of in-hospital mortality for elderly VTE patients are unknown.

Methods and results: Among 1247 consecutive patients with acute VTE from the prospective SWIss Venous ThromboEmbolism Registry (SWIVTER), 644 (52%) were elderly (≥65 years of age). In comparison to younger patients, the elderly more often had pulmonary embolism (PE) (60 vs. 42%; P< 0.001), cancer (30 vs. 20%; P< 0.001), chronic lung disease (14 vs. 8%; P= 0.001), and congestive heart failure (12 vs. 2%; P< 0.001). Elderly VTE patients were more often hospitalized (75 vs. 52%; P< 0.001), and there was no difference in the use of thrombolysis, catheter intervention, or surgical embolectomy between the elderly and younger PE patients (5 vs. 6%; P= 0.54), despite a trend towards a higher rate of massive PE in the elderly (8 vs. 4%; P= 0.07). The overall in-hospital mortality rate was 6.6% in the elderly vs. 3.2% in the younger VTE patients (P= 0.033). Cancer was associated with in-hospital death both in the elderly [hazard ratio (HR) 4.91, 95% confidence interval (CI) 2.32-10.38; P< 0.001] and in the younger patients (HR 4.90, 95% CI 1.37-17.59; P= 0.015); massive PE was a predictor of in-hospital death in the elderly only (HR 3.77, 95% CI 1.63-8.74; P= 0.002).

Conclusion: Elderly patients had more serious VTE than younger patients, and massive PE was particularly life-threatening in the elderly.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Compression Bandages / statistics & numerical data
  • Female
  • Fibrinolytic Agents / therapeutic use
  • Hospital Mortality*
  • Humans
  • Male
  • Middle Aged
  • Prospective Studies
  • Pulmonary Embolism / mortality
  • Pulmonary Embolism / therapy
  • Recurrence
  • Registries
  • Reperfusion / mortality
  • Reperfusion / statistics & numerical data
  • Switzerland / epidemiology
  • Thrombectomy / mortality
  • Thrombectomy / statistics & numerical data
  • Thrombolytic Therapy / mortality
  • Thrombolytic Therapy / statistics & numerical data
  • Treatment Outcome
  • Venous Thromboembolism / mortality*
  • Venous Thromboembolism / therapy

Substances

  • Fibrinolytic Agents